Literature DB >> 25120391

Heart failure in remission for more than 13 years after removal of a left ventricular assist device.

Ana Maria Segura1, Lamia Dris1, Edward K Massin1, Fred J Clubb1, L Maximilian Buja1, O H Frazier1, Heinrich Taegtmeyer1.   

Abstract

Mechanical cardiac unloading with use of a left ventricular assist device (LVAD) is associated with substantial improvements in left ventricular function and enables subsequent LVAD explantation in some patients. We describe the case of a 35-year-old man with dilated nonischemic cardiomyopathy who was supported with an LVAD for 9 months. After the device was removed, he led a normal life for 13 years and 4 months. However, at 49 years of age, he presented with new signs and symptoms of heart failure, necessitating implantation of a 2nd LVAD. Afterwards, he has remained asymptomatic. This case is unique in that the patient lived a normal life for longer than a decade before renewed left ventricular decompensation necessitated repeat LVAD therapy. Histologic examination revealed few changes between the first device's removal in 1999 and the 2nd device's implantation in 2012.

Entities:  

Keywords:  Cardiomyopathy, dilated/physiopathology/therapy; device removal; heart failure/physiopathology/therapy; heart-assist devices; myocytes, cardiac/pathology; recovery of function/physiology; recurrence; time factors; treatment outcome; ventricular dysfunction, left/physiology; ventricular remodeling

Mesh:

Year:  2014        PMID: 25120391      PMCID: PMC4120501          DOI: 10.14503/THIJ-13-4029

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  37 in total

1.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

2.  Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.

Authors:  Simon Maybaum; Donna Mancini; Steve Xydas; Randall C Starling; Keith Aaronson; Francis D Pagani; Leslie W Miller; Kenneth Margulies; Susan McRee; O H Frazier; Guillermo Torre-Amione
Journal:  Circulation       Date:  2007-05-07       Impact factor: 29.690

Review 3.  Cardiac recovery during mechanical assist device support.

Authors:  Simon Maybaum; Gayathri Kamalakannan; Sandhya Murthy
Journal:  Semin Thorac Cardiovasc Surg       Date:  2008

4.  Histopathologic correlates of myocardial improvement in patients supported by a left ventricular assist device.

Authors:  Ana Maria Segura; O H Frazier; Zumrut Demirozu; L Maximilian Buja
Journal:  Cardiovasc Pathol       Date:  2010-02-25       Impact factor: 2.185

Review 5.  Clinical, molecular, and genomic changes in response to a left ventricular assist device.

Authors:  Jennifer L Hall; David R Fermin; Emma J Birks; Paul J R Barton; Mark Slaughter; Peter Eckman; Hideo A Baba; Jeremias Wohlschlaeger; Leslie W Miller
Journal:  J Am Coll Cardiol       Date:  2011-02-08       Impact factor: 24.094

6.  Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.

Authors:  Jennifer L Hall; Emma J Birks; Suzanne Grindle; Martin E Cullen; Paul J Barton; James E Rider; Sangjin Lee; Subash Harwalker; Ami Mariash; Neeta Adhikari; Nathan J Charles; Leanne E Felkin; Sean Polster; Robert S George; Leslie W Miller; Magdi H Yacoub
Journal:  Eur Heart J       Date:  2006-11-28       Impact factor: 29.983

Review 7.  Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and molecular effects.

Authors:  Amrut V Ambardekar; Peter M Buttrick
Journal:  Circ Heart Fail       Date:  2011-03       Impact factor: 8.790

Review 8.  The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.

Authors:  Craig R Butler; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

9.  Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation.

Authors:  Emma J Birks; Robert S George; Ashi Firouzi; Gavin Wright; Toufan Bahrami; Magdi H Yacoub; Asghar Khaghani
Journal:  J Thorac Cardiovasc Surg       Date:  2012-04-11       Impact factor: 5.209

10.  A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure.

Authors:  Ravi Ramani; Deborah Vela; Ana Segura; Dennis McNamara; Bonnie Lemster; Vishnupriya Samarendra; Robert Kormos; Yoshiya Toyoda; Christian Bermudez; O H Frazier; Christine S Moravec; John Gorcsan; Heinrich Taegtmeyer; Charles F McTiernan
Journal:  J Am Coll Cardiol       Date:  2011-11-22       Impact factor: 24.094

View more
  3 in total

Review 1.  Epidemiology of "Heart Failure with Recovered Ejection Fraction": What do we do After Recovery?

Authors:  Johny S Kuttab; Michael S Kiernan; Amanda R Vest
Journal:  Curr Heart Fail Rep       Date:  2015-12

2.  A PKM2 signature in the failing heart.

Authors:  Meredith L Rees; Janani Subramaniam; Yuanteng Li; Dale J Hamilton; O Howard Frazier; Heinrich Taegtmeyer
Journal:  Biochem Biophys Res Commun       Date:  2015-02-28       Impact factor: 3.575

3.  Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.

Authors:  Shi Shen; Lorenzo R Sewanan; Stuart G Campbell
Journal:  J Mol Cell Cardiol       Date:  2021-05-14       Impact factor: 5.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.